Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06303-7Source: DataRank Database

Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients is a research paper published in Breast Cancer Research and Treatment (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.39)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Paula D. Strassle ORCID,Guilherme C. de Oliveira ORCID,Chris B. Agala ORCID,Philip M. Spanheimer ORCID,Kristalyn K. Gallagher ORCID

Live enrichment

PubMed:34176085 PMC:PMC8363582 OpenAlex:https://openalex.org/W3163239667

National Cancer Institute

Grant: 5K12CA120780-12

UNC Oncology Clinical/Translational Research Training Program (OCT-RTP)

NCI NIH HHS

Grant: K12 CA120780

Intramural NIH HHS

Grant: Z99 MD999999

National Center on Minority Health and Health Disparities

FWCI

0.39

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

2025

greenLicense: CC BY

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8363582

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-021-06303-7.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-021-06303-7/fulltext.html

journalhttps://doi.org/10.1007/s10549-021-06303-7

Fields of Study

Breast Cancer Treatment StudiesEconomic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of Life03 medical and health sciences0302 clinical medicineAdultBreast NeoplasmsChemotherapy, AdjuvantCombined Modality TherapyFemaleHumansMastectomy, SegmentalNeoplasm StagingTreatment Outcome

MeSH Terms

AdultBreast NeoplasmsCombined Modality TherapyFemaleHumansNeoplasm StagingMastectomy, SegmentalTreatment OutcomeChemotherapy, Adjuvant

Keywords

Breast cancerMedicineOncologyInternal medicineBreast-conserving surgeryMastectomyCancerSurgeryGynecologyAdjuvant ChemotherapyHealthcare DisparitiesAdjuvant RadiotherapyTriple-negative Breast CancerHer2-positive Breast CancerAdultTreatment OutcomeChemotherapy, AdjuvantHumansBreast NeoplasmsFemaleMastectomy, SegmentalCombined Modality TherapyNeoplasm Staging

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being